阿片类药物治疗项目中病毒性肝炎与HIV检测及衔接照护
在美国一个阿片类药物治疗项目内实施选择性退出(opt-out)的病毒性肝炎和HIV检测及衔接照护项目,2018年3月至2019年2月共筛查532人, HCV抗体阳性34%、HCV RNA阳性20%,57%的HCV RNA阳性者就诊专科,43%启动治疗,41%完成治疗;4例诊断乙肝,0例诊断HIV。
要点
- 阿片类药物治疗项目中HCV RNA阳性率达20%,提示该人群HCV负担高。
- 实施筛查与导航方案后57%的HCV RNA阳性者就诊专科,43%启动治疗。
- 有初级保健提供者的人群最可能启动HCV治疗。
核心结论
- 在阿片类药物治疗项目中实施选择性退出筛查和导航方案,可显著提高病毒性肝炎的识别和治疗。
研究设计与样本
- 在美国一个阿片类药物治疗项目内实施选择性退出病毒性肝炎和HIV检测及衔接照护项目,对所有入组者筛查并每年评估复筛。
主要发现
- 2018年3月至2019年2月共筛查532人,HCV抗体阳性180人(34%),HCV RNA阳性108人(20%)。
- 4人诊断乙肝,0人诊断HIV。
临床怎么用
- 在阿片类药物治疗项目中推行选择性退出HCV和HIV筛查,并配备患者导航员提供咨询和衔接照护。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
原文
BACKGROUND: In the United States, many opioid treatment programs (OTPs) do not offer viral hepatitis (VH) or human immunodeficiency virus (HIV) testing despite high prevalence among OTP clients. We initiated an opt-out VH and HIV testing and linkage-to-care program within our OTP. METHODS: All OTP intakes are screened for VH and HIV and evaluated for rescreening annually. A patient navigator reviews laboratory results and provides counseling in the OTP clinic. The medical record is queried to identify individuals with previously diagnosed, untreated VH or HIV. Navigation support is provided for linkage or relinkage to VH or HIV care. RESULTS: Between March 2018 and Februrary 2019, 532 individuals were screened for hepatitis C virus (HCV), 180 tested HCV antibody positive (34%), and 108 were HCV-ribonucleic acid (RNA) positive (20%). Sixty individuals were identified with previously diagnosed, untreated HCV. Of all HCV RNA+, 49% reported current injection drug use (82 of 168). Ninety-five individuals were seen by an HCV specialist (57% of HCV RNA+), 72 started treatment (43%), and 69 (41%) completed treatment. Individuals with primary care providers were most likely to start treatment. Four individuals were diagnosed with hepatitis B; 0 were diagnosed with HIV. CONCLUSIONS: The implementation of an OTP-based screening and navigation protocol has enabled significant gains in the identification and treatment of VH in this high prevalence setting.
引用
- Rowan SE, Kamis KF, Beum R, et al. Viral Hepatitis and Human Immunodeficiency Virus Testing and Linkage to Care for Individuals Enrolled in an Opioid Treatment Program. J Infect Dis. 2020. PMID: 32877565. doi:10.1093/infdis/jiz694
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。